Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
24.04
+0.31 (1.31%)
Aug 7, 2025, 12:58 PM - Market open

Sage Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
3,0363,9697,0935,7184,6034,332
Upgrade
Market Cap Growth
-53.27%-44.04%24.06%24.22%6.25%121.45%
Upgrade
Enterprise Value
3,0924,0366,7375,1234,3853,977
Upgrade
Last Close Price
23.7331.9159.8651.7147.2857.20
Upgrade
PS Ratio
3.935.0817.8975.8169.1517.28
Upgrade
PB Ratio
19.1617.3736.4733.6623.1721.18
Upgrade
P/TBV Ratio
19.1717.3736.4733.6623.1721.18
Upgrade
EV/Sales Ratio
4.105.1716.9967.9265.8715.87
Upgrade
Debt / Equity Ratio
3.012.060.570.661.061.85
Upgrade
Asset Turnover
0.880.930.510.090.070.37
Upgrade
Inventory Turnover
3.113.633.156.35--
Upgrade
Quick Ratio
3.013.712.343.565.937.03
Upgrade
Current Ratio
3.774.253.104.296.257.15
Upgrade
Return on Equity (ROE)
-108.49%-93.55%-290.14%-353.93%-370.20%-288.86%
Upgrade
Return on Assets (ROA)
-13.76%-12.32%-41.73%-45.27%-36.39%-19.79%
Upgrade
Return on Capital (ROIC)
-17.41%-20.54%-109.93%-107.49%-67.63%-34.54%
Upgrade
Earnings Yield
-7.61%-4.98%-7.45%-11.41%-16.21%-7.96%
Upgrade
FCF Yield
0.15%-2.22%-8.39%-9.01%-12.26%-3.83%
Upgrade
Buyback Yield / Dilution
-2.43%-4.40%-11.84%-25.70%-12.32%-20.79%
Upgrade
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q